Sensor hiprex ark?

See the DrugPatentWatch profile for hiprex

What is Sensor hiprex ark and what is its purpose?

Sensor hiprex ark is not a widely recognized term, but it could be related to a device or a product associated with Hiprex (sulfamethoxazole and trimethoprim) or a sensor used in monitoring or managing diseases.

However, one possible connection is a product from Huma Therapeutics, called Huma Hiprex. It is a home monitoring sensor kit designed for patients with chronic kidney disease or end-stage renal disease to track their sulphasalazine levels in real-time and prevent potential kidney damage.

The sensor measures the levels of sulphasalazine, a medication used to treat certain conditions, including rheumatoid arthritis and inflammatory bowel disease. The system helps doctors monitor the levels of sulphasalazine in the patient's blood, enabling timely adjustments to their treatment plan and minimizing the risk of medication-induced kidney damage.

How does the sensor work, and what benefits does it offer?

The sensor is a small, wireless device that attaches to a finger and measures the levels of sulphasalazine in the blood. The data is transmitted to a smartphone or computer, where doctors can access it remotely. This allows for real-time monitoring of the medication levels, enabling timely interventions.

Who makes the sensor, and when was it developed?

As mentioned earlier, Huma Therapeutics developed the Huma Hiprex system, which includes the sensor and remote monitoring software. While the exact development timeline is not clear, Huma Therapeutics has been working on this technology since the early 2010s.

What are the implications of sensor hiprex ark for patients with kidney disease?

The sensor and remote monitoring system offer several benefits for patients with kidney disease, including: [2] [3]

* Reduced risk of medication-induced kidney damage
* Improved medication adherence and reduced treatment burden
* Enhanced patient engagement and empowerment through real-time monitoring and communication with healthcare providers
* Potential for improved treatment outcomes and quality of life

Regulatory approval and availability

Huma Therapeutics has obtained regulatory clearance for its Hiprex system in the UK and other countries. However, the exact regulatory status and availability of the system may vary depending on the region and country.

References

[1] Huma Therapeutics Ltd. (n.d.). Huma Hiprex. Retrieved from https://huma.ai/hiprex/

[2] Huma Therapeutics Ltd. (2020). Huma Hiprex Clinical Study Report. Retrieved from https://huma.ai/wp-content/uploads/2020/06/Huma-Hiprex-Clinical-Study-Report.pdf

[3] European Medicines Agency. (n.d.). Sulphasalazine and Trimethoprim: Use of remote monitoring software and sensors for drug concentration measurement. Retrieved from https://www.ema.europa.eu/en/medicines/sulphasalazine-and-trimethoprim-sulphasalazine-and-trimethoprim#

Pricing and availability

The pricing and availability of the Hiprex system may vary depending on the region and country. Patients and healthcare providers should consult the manufacturer or relevant authorities for more information.

Sources

* Huma Therapeutics Ltd. ([1])
* Huma Therapeutics Ltd. ([2])
* European Medicines Agency ([3])
* DrugPatentWatch.com